-
公开(公告)号:US20170135958A1
公开(公告)日:2017-05-18
申请号:US15416459
申请日:2017-01-26
Inventor: Allison R. Ficht , Kenneth Carson , Cynthia Sheffield , John Herbert Waite
CPC classification number: A61K9/5052 , A61K9/0019 , A61K9/1652 , A61K9/1658 , A61K9/5036 , A61K9/5089 , A61K38/17 , A61K38/21 , A61K39/0003 , A61K39/08 , A61K2039/542 , A61K2039/575 , A61K2039/6031 , Y02A50/403 , Y02A50/478 , Y02A50/489 , A61K2300/00
Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
-
公开(公告)号:US20160207971A1
公开(公告)日:2016-07-21
申请号:US15073809
申请日:2016-03-18
Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
Inventor: Allison Ficht , Theresa Good , Kenneth Carson , Sungmun Lee
CPC classification number: C07K14/44 , A61K38/00 , C07K14/4702 , C07K14/4711 , C07K2319/35
Abstract: The present inventions are compositions and methods of using at least a portion of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
Abstract translation: 本发明是使用至少一部分分离和纯化的α-晶状蛋白多肽的组合物和方法,所述α-晶状体蛋白多肽包括一个或多个复合片,并且可防止神经毒性和淀粉样变。
-
公开(公告)号:US09321817B2
公开(公告)日:2016-04-26
申请号:US14251709
申请日:2014-04-14
Applicant: The Texas A&M University System
Inventor: Allison Ficht , Theresa Good , Kenneth Carson , Sungmun Lee
IPC: A61K38/17 , A61K39/00 , A61K39/002 , C07K14/44 , A61K38/00
CPC classification number: C07K14/44 , A61K38/00 , C07K14/4702 , C07K14/4711 , C07K2319/35
Abstract: The present inventions are compositions and methods of using at least a portion of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
Abstract translation: 本发明是使用至少一部分分离和纯化的α-晶状蛋白多肽的组合物和方法,所述α-晶状体蛋白多肽包括一个或多个复合片,并且可防止神经毒性和淀粉样变。
-
公开(公告)号:US09802991B2
公开(公告)日:2017-10-31
申请号:US15073809
申请日:2016-03-18
Applicant: THE TEXAS A&M UNIVERSITY SYSTEM
Inventor: Allison Ficht , Theresa Good , Kenneth Carson , Sungmun Lee
CPC classification number: C07K14/44 , A61K38/00 , C07K14/4702 , C07K14/4711 , C07K2319/35
Abstract: The present inventions are compositions and methods of using at least a portion of an isolated and purified α-crystallin polypeptide that includes one or more β-pleated sheets and that prevents neurotoxicity and amyloidogenesis.
-
公开(公告)号:US10952970B2
公开(公告)日:2021-03-23
申请号:US15416459
申请日:2017-01-26
Inventor: Allison R. Ficht , Kenneth Carson , Cynthia Sheffield , John Herbert Waite
IPC: A61K8/11 , A61K38/17 , A61K9/50 , A61K9/16 , A61K39/00 , A61K9/00 , A61K38/21 , A61K39/08 , A61K38/00
Abstract: The present invention includes compositions and methods for the use of an encapsulation additive having between about 0.1 to about 30 percent isolated and purified vitelline protein B to provide for mixed and extended release formulations.
-
-
-
-